Regeneron’s Marion McCourt sells 566 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Regeneron Pharmaceuticals, Inc. (REGN) — EVP Commercial Marion McCourt reported direct sales of 566 common shares across 13 transactions on November 16, 2026, at reported per-share prices ranging from $952.79 to $971.93. The sales were made under a Rule 10b5-1 plan adopted February 17, 2026. A separate holding entry lists 219 shares indirectly held through a 401(k) plan.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 44 | $952.79 | $42K |
| Sale | Common Stock F1, F3 | 59 | $954.46 | $56K |
| Sale | Common Stock F1 | 30 | $955.51 | $29K |
| Sale | Common Stock F1 | 22 | $956.01 | $21K |
| Sale | Common Stock F1, F4 | 44 | $958.47 | $42K |
| Sale | Common Stock F1, F5 | 66 | $959.46 | $63K |
| Sale | Common Stock F1, F6 | 49 | $960.31 | $47K |
| Sale | Common Stock F1, F7 | 59 | $961.36 | $57K |
| Sale | Common Stock F1, F8 | 41 | $962.44 | $39K |
| Sale | Common Stock F1, F9 | 42 | $963.70 | $40K |
| Sale | Common Stock F1 | 21 | $964.69 | $20K |
| Sale | Common Stock F1, F10 | 63 | $965.62 | $61K |
| Sale | Common Stock F1 | 26 | $971.93 | $25K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (10)
- F1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 17, 2026.
- F2. Represents volume-weighted average price of sales of 44 shares of Company stock on November 16, 2026 at prices ranging from $952.64 to $952.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F3. Represents volume-weighted average price of sales of 59 shares of Company stock on November 16, 2026 at prices ranging from $954.44 to $954.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F4. Represents volume-weighted average price of sales of 44 shares of Company stock on November 16, 2026 at prices ranging from $958.29 to $958.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F5. Represents volume-weighted average price of sales of 66 shares of Company stock on November 16, 2026 at prices ranging from $959.18 to $959.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F6. Represents volume-weighted average price of sales of 49 shares of Company stock on November 16, 2026 at prices ranging from $960.07 to $960.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F7. Represents volume-weighted average price of sales of 59 shares of Company stock on November 16, 2026 at prices ranging from $961.26 to $961.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F8. Represents volume-weighted average price of sales of 41 shares of Company stock on November 16, 2026 at prices ranging from $962.15 to $962.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F9. Represents volume-weighted average price of sales of 42 shares of Company stock on November 16, 2026 at prices ranging from $963.32 to $963.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
- F10. Represents volume-weighted average price of sales of 63 shares of Company stock on November 16, 2026 at prices ranging from $965.38 to $965.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2026 at each separate price.
Key Figures
Key Terms
Rule 10b5-1(c) regulatory
volume-weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.